Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

32%

7 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed with results

Key Signals

2 with results86% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (9)
P 2 (2)
P 3 (3)
P 4 (4)

Trial Status

Unknown8
Completed6
Recruiting3
Not Yet Recruiting2
Withdrawn1
Terminated1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT06051110Not ApplicableCompleted

Individual Patient Data Meta-analysis on Prehospital Risk Assessment in Patients Suspected of Non-ST-segment Elevation Acute Coronary Syndrome

NCT07252245Not ApplicableNot Yet RecruitingPrimary

Pre Hospital Triage of Patients at Intermediate and High Risk for ACS

NCT06197724RecruitingPrimary

MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

NCT06695429Not ApplicableRecruitingPrimary

Supplementation With Beetroot Juice to Prevent Contrast Associated Nephropathy During Hospitalization for Acute Coronary Syndrome Without ST Elevation

NCT05117866Not ApplicableActive Not Recruiting

Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study

NCT05250596Phase 2CompletedPrimary

COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS)

NCT06255678Recruiting

Angio-based Final Functional Effect of PCI

NCT04400500CompletedPrimary

Differential Diagnosis and Risk Stratification in Patients With Suspected NSTEACS

NCT06096909Not ApplicableNot Yet Recruiting

Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population

NCT04476173Phase 3Unknown

ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction

NCT05125276Phase 4UnknownPrimary

Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients

NCT05779059Phase 3UnknownPrimary

Prasugrel Or Ticagrelor De-escalation in NSTE-ACS

NCT04766437Phase 2CompletedPrimary

Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy

NCT02073565Not ApplicableCompleted

HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt

NCT05202041Not ApplicableUnknownPrimary

Non-IRA Functional Evaluation With AccuFFRangio in NSTE-ACS

NCT03300167Not ApplicableWithdrawnPrimary

Study of the Vascular Response to Percutaneous Coronary Intervention in Patients With Non-ST-elevation Acute Coronary Syndromes Using Intravascular Blood Sampling

NCT02892903Not ApplicableUnknown

In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes?

NCT03863327Unknown

EKG Criteria and Identification of Acute Coronary Occlusion

NCT01962428Phase 4CompletedPrimary

Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI

NCT02071966Phase 4TerminatedPrimary

Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS

Scroll to load more

Research Network

Activity Timeline